Addition of bevacizumab to paclitaxel/carboplatin in first-line management of advanced ovarian cancer: Results of the GOG 0218 phase III study

Kristin Garcia, Aarati Ranganathan, Robert Coleman

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalClinical Ovarian Cancer
Volume3
Issue number2
DOIs
StatePublished - Nov 1 2010

Fingerprint

Carboplatin
Paclitaxel
Ovarian Neoplasms
Bevacizumab

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this

Addition of bevacizumab to paclitaxel/carboplatin in first-line management of advanced ovarian cancer : Results of the GOG 0218 phase III study. / Garcia, Kristin; Ranganathan, Aarati; Coleman, Robert.

In: Clinical Ovarian Cancer, Vol. 3, No. 2, 01.11.2010.

Research output: Contribution to journalArticle

@article{d52a7976841c4b008e220c7003da7d1b,
title = "Addition of bevacizumab to paclitaxel/carboplatin in first-line management of advanced ovarian cancer: Results of the GOG 0218 phase III study",
author = "Kristin Garcia and Aarati Ranganathan and Robert Coleman",
year = "2010",
month = "11",
day = "1",
doi = "10.3816/COC.2010.n.020",
language = "English (US)",
volume = "3",
journal = "Clinical Ovarian Cancer",
issn = "1941-4390",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Addition of bevacizumab to paclitaxel/carboplatin in first-line management of advanced ovarian cancer

T2 - Results of the GOG 0218 phase III study

AU - Garcia, Kristin

AU - Ranganathan, Aarati

AU - Coleman, Robert

PY - 2010/11/1

Y1 - 2010/11/1

UR - http://www.scopus.com/inward/record.url?scp=79951859252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951859252&partnerID=8YFLogxK

U2 - 10.3816/COC.2010.n.020

DO - 10.3816/COC.2010.n.020

M3 - Article

AN - SCOPUS:79951859252

VL - 3

JO - Clinical Ovarian Cancer

JF - Clinical Ovarian Cancer

SN - 1941-4390

IS - 2

ER -